At the cellular level, our results confirmed a significantdecrease in cytoplasmic levels of α-syn and in α-syn aggregatesin DAns from LRRK2-PD-iPSC treated during 48 h with non-cytotoxicconcentrations of bow-tie dendrimer III. Here, LRRK2 is linked to Parkinson disease.